Go to Page # Page of 90
loading

Vestibular Schwannoma: Pathogenesis and Treatment Development

 D. Bradley Welling, MD, PhD
  24th-Jul-2009
Description: Drug development for treatment of Vestibular Schwannomas (VS) based upon improved understanding of the growth pathways which lead to targeted pharmacologic intervention. Summarize stereotactic radiation data in the treatment of VS and includes Case studies.
Views: 2956
Domain: Medical
Category: Therapy
weSRCH App on Apple
Contents:
Vestibular Schwannoma Update 2009: Pathogenesis and Treatment Development
Fitz-Hugh Symposium June 12 , 2009
D. Bradley Welling, MD, PhD The Ohio State University

Financial disclosure
� I have no financial interest to disclose � Off label drugs will be discussed but not recommended for treatment

Goals
Drug development for treatment of VS based upon improved understandin ... See more

Recent Presentations

...
19 April, 2019

FDA Approach to the Opioids Crisis

Opioid Crisis is not one crisis, but multiple challenges to prescribers, patients & healthcare system. FDA is working in a prioritized way in multiple areas to confront opioid over

...
18 April, 2019
Ralph F. Hall
17 April, 2019